FIORETTO, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 10877
EU - Europa 996
AS - Asia 589
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12464
Nazione #
US - Stati Uniti d'America 10873
CN - Cina 514
FI - Finlandia 270
IT - Italia 185
SE - Svezia 163
UA - Ucraina 155
DE - Germania 153
VN - Vietnam 44
GB - Regno Unito 29
IE - Irlanda 14
FR - Francia 11
NL - Olanda 9
IN - India 8
TH - Thailandia 8
TR - Turchia 4
CA - Canada 3
LU - Lussemburgo 2
MY - Malesia 2
PH - Filippine 2
TW - Taiwan 2
A1 - ???statistics.table.value.countryCode.A1??? 1
CZ - Repubblica Ceca 1
EU - Europa 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
KR - Corea 1
MX - Messico 1
PK - Pakistan 1
RO - Romania 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 12464
Città #
Fairfield 2140
Woodbridge 1284
Houston 1101
Ann Arbor 855
Ashburn 778
Cambridge 730
Seattle 708
Chandler 696
Wilmington 696
Jacksonville 640
Princeton 335
San Diego 186
Medford 155
Nanjing 121
Des Moines 111
Roxbury 107
Beijing 98
Helsinki 98
Boardman 70
Padova 56
Guangzhou 54
Dong Ket 44
Hebei 36
Shenyang 36
Jiaxing 29
Tianjin 29
Norwalk 28
Nanchang 27
Changsha 17
Redwood City 15
Dublin 14
Jinan 13
Borås 11
Kharkiv 11
Rovigo 10
Zhengzhou 9
Rockville 7
Chicago 6
Gavirate 5
Hefei 5
Shanghai 5
Hangzhou 4
Lendinara 4
Milan 4
Ningbo 4
Selvazzano Dentro 4
Taizhou 4
Venice 4
Chengdu 3
Duncan 3
Falls Church 3
Haikou 3
Indiana 3
Kunming 3
Lanzhou 3
Leawood 3
London 3
Rivignano 3
San Francisco 3
Wuhan 3
Chieti 2
Costa Mesa 2
Groningen 2
Hanover 2
Luxembourg 2
Naples 2
Napoli 2
Novoli 2
Redmond 2
Rome 2
Sassari 2
Silea 2
Yenibosna 2
Aci Sant'antonio 1
Amsterdam 1
Augusta 1
Bangkok 1
Bari 1
Bologna 1
Brandizzo 1
Bratislava 1
Cadoneghe 1
Camisano Vicentino 1
Campodarsego 1
Camposampiero 1
Capua 1
Casalnuovo Di Napoli 1
Chilly-mazarin 1
Dearborn 1
Fuzhou 1
Galati 1
Geislingen an der Steige 1
Guiyang 1
Iesi 1
Izmir 1
Jakarta 1
Kherson 1
Kuala Lumpur 1
Lahore 1
Livorno 1
Totale 11493
Nome #
Modifications of Resting Energy Expenditure After Sleeve Gastrectomy 168
Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries. 154
SGLT2 Inhibitors and the Diabetic Kidney 132
Incidence and Predictors of Hypoglycemia 1 Year After Laparoscopic Sleeve Gastrectomy 120
Characterization of subcutaneous and omental adipose tissue in patients with obesity and with different degrees of glucose impairment 115
Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. 109
Diagnostic pathways of the complex patients: rapid intensive observation in an Acute Medical Unit. 108
Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable 108
Impaired Response To Angiotensin-ii In Type-1 (insulin-dependent) Diabetes-mellitus - Role of Prostaglandins and Sodium-lithium Countertransport Activity 102
The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects 98
null 98
Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive type 2 diabetic patients with microalbuminuria: DIAL study. 96
Patterns of renal injury in NIDDM patients with microalbuminuria 95
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus 95
Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus 94
Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. 91
Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment 91
The ideal blood pressure target to prevent cardiovascular disease in type 2 diabetes: A neutral viewpoint. 90
Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19 90
High-protein diet: a barrier for sodium-glucose co-transporters 2 inhibitors nephroprotective effects? 90
Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. 88
Metabolic control of kidney hemodynamics in normal and insulin-dependent diabetic subjects. Effects of acetoacetic, lactic, and acetic acids. 85
Five-year predictors of insulin initiation in people with type 2 diabetes under real-life conditions 84
Ketone bodies increase glomerular filtration rate in normal man and in patients with Type 1 (insulin-dependent) diabetes mellitus 84
Mechanisms linking empagliflozin to cardiovascular and renal protection 83
Biological Variability of Estimated GFR and Albuminuria in CKD 83
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 83
Renal protection in diabetes: role of glycemic control. 81
Type I diabetes is characterized by insulin resistance not only with regard to glucose, but also to lipid and amino acid metabolism. 80
The kidney in type 2 diabetes: focus on renal structure. 80
Renal structure incaucasian noninsulindependent diabetic patients. 79
Nitric oxide modulation of renal and cardiac hemodynamics in type 2 diabetes 79
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study 79
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences 79
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia 79
Diabetic Nephropathy 78
Renal structure in type 2 diabetes 78
Type I insulin-dependent diabetic patients show an impaired renal hemodynamic response to protein intake. 78
Cardiac injury and mortality in patients with Coronavirus disease 2019 (COVID-19): insights from a mediation analysis 77
Relationships Among Natriuresis, Atrial-natriuretic-peptide and Insulin In Insulin-dependent Diabetes 77
The kidney in diabetes: dynamic pathways of injury and repair. 76
Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure 76
Porcine and human insulin absorption from subcutaneous tissues in normal and insulin dependent diabetic subjects: a deconvolution-based approach 76
Impaired renal response to a meat meal in insulin-dependent diabetes: role of glucagon and prostaglandins. 76
Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients 76
Long-term blood pressure variability and development of chronic kidney disease in type 2 diabetes 76
Tubular Na+ handling in type I insulin-dependent diabetics during saline and ketone body infusion 75
Diabetic nephropathy: renal structural studies in type 1 and type 2 diabetic patients 75
Acute phase markers of inflammation and glomerular structure in type 2 diabetic patients 75
Histopathology of diabetic nephropathy. 74
Bariatric surgery improves atherogenic LDL profile by triglyceride reduction 74
Overall quality of care predicts the variability of key risk factors for complications in type 2 diabetes: An observational, longitudinal retrospective study 74
Antihypertensive treatment and multifactorial approach for renal protection in diabetes 73
Reversal of lesions of diabetic nephropathy after pancreas transplantation. 72
A defect in glycogen synthesis characterizes insulin resistance in hypertensive patients with type 2 diabetes 72
Glucose and ketone body turnover in carnitine-palmitoyl-transferase deficiency. 72
Reversibility of diabetic nephropathy lesions: a new concept 72
Long-Term Safety of Dapagliflozin in Older Patients with Type 2 Diabetes Mellitus: A Pooled Analysis of Phase IIb/III Studies 72
Tacrolimus and cyclosporine nephrotoxicity in native kidneys of pancreas transplant recipients. 71
Mesangial expansion in diabetic nephropathy: functional and genetic considerations. 71
Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. 71
Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. 71
Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. 71
Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals 71
The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? 70
The effect of dapagliflozin on renal function in patients with type 2 diabetes 70
Role of Atrial-natriuretic-peptide In the Pathogenesis of Sodium Retention In Iddm With and Without Glomerular Hyperfiltration 70
Growth factors and diabetic nephropathy: kidney structure and therapeutic interventions. 69
Cyclosporine associated lesions in native kidneys of diabetic pancreas transplant recipients. 69
Reversal of diabetic nephropathy: lessons from pancreas transplantation. 69
Dapagliflozin: potential beneficial effects in the prevention and treatment of renal and cardiovascular complications in patients with type 2 diabetes 69
Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: The AMD annals initiative 69
Pathophysiology of diabetic complications. 68
Vascular endothelial growth factor (VEGF) and VEGF receptors in diabetic nephropathy: expression studies in biopsies of type 2 diabetic patients 68
Is diabetic nephropathy reversible? 68
Enhancing the predictive value of urinary albumin for diabetic nephropathy 68
Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes 68
Normoalbuminuric kidney impairment in patients with T1DM: Insights from annals initiative 68
Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin 68
Residual microvascular risk in diabetes: unmet needs and future directions. 67
Sequential renal biopsies in insulin-dependent diabetic patients: structural factors associated with clinical progression. 67
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration 67
Patterns of renal injury in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. 66
Residual macrovascular risk in 2013: what have we learned? 65
Effects of pancreas transplantation on the prevention and reversal of diabetic nephropathy 65
Apparent treatment resistant hypertension, blood pressure control and the progression of chronic kidney disease in patients with type 2 diabetes 65
Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study 65
CELLULAR BASIS OF DIABETIC NEPHROPATHY: IV ANTIOXIDANT ENZYME MRNA EXPRESSION LEVELS IN SKIN FIBROBLASTS OF TYPE 1 DIABETIC SIBLING PAIRS. 64
SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis 64
Renal structure in type 2 diabetic patients with microalbuminuria 63
Does microvascular disease predict macrovascular events in type 2 diabetes? 63
Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease. 63
Ketone body metabolism: a physiological and clinical overview. 63
Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM. 63
SARS-CoV-2 RNA identification in nasopharyngeal swabs: Issues in pre-analytics 63
Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference 62
Effects of atrial natriuretic peptide infusion on kidney function in normotensive type 1 (insulin-dependent) diabetic patients before and after enalapril treatment. 62
Ultrastructural measures of glomerular extracellular matrix accumulation in non-proteinuric type 2 diabetic patients. 61
Glomerulo barrier dysfunction in glomerulosclerosis-resistent Milan rat with experimental diabetes: the role of renal hemodynamics. 61
The angiotensin-converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes 61
Totale 7891
Categoria #
all - tutte 20462
article - articoli 19106
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 967
Totale 40535


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018155 0000 00 032 401181
2018/20191560 602018 1318 15106 18233457485
2019/20203000 48711162265 324234 271365 299234202146
2020/20212420 97164142315 153163 92208 350183285268
2021/20222454 98281255190 148125 108264 12871245541
2022/20231311 46513621141 305205 335 0000
Totale 12589